T1	SectionAnnotate 113 140	History of Present Illness:
T2	SectionAnnotate 1901 1912	IMPRESSION:
T4	SectionAnnotate 3035 3056	Past Medical History:
T5	SectionAnnotate 3589 3611	Past Surgical History:
T6	SectionSkip 3823 4382	Current Medications           Current Outpatient 
 Prescriptions   Medication Sig Dispense Refill    clotrimazole-betamethasone (LOTRISONE) 1-0.05 % cream 2 (two) times a day.      ibuprofen (ADVIL,MOTRIN) 800 mg tablet Take 800 mg by mouth once as needed for Pain.      omeprazole (PRILOSEC) 20 mg capsule Take 20 mg by mouth As needed after meals.      triamterene-hydrochlorothiazide (DYAZIDE) 37.5-25 mg capsule Take 1 capsule by mouth Daily.      predniSONE (DELTASONE) 5 mg tablet        No current facility-administered medications for this visit.
T7	SectionAnnotate 4394 4409	Social History:
T8	SectionAnnotate 4828 4852	Social History Narrative
T9	SectionAnnotate 5096 5114	Review of Systems:
T11	SectionSkip 5137 6155	Physical Examination:   General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - sclera anicteric  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy, no hepatosplenomegaly  Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm, normal S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  lap chole scars  Breasts - left breast normal without mass, skin or nipple changes or axillary nodes, abnormal mass palpable in 
 the right breast at 9:00 6cm FN that measures 4x4cm  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
T12	PROBLEM 48 73	early stage breast cancer
T13	TREATMENT 90 109	neoadjuvant therapy
T14	PROBLEM 179 270	a recently diagnosed right sided invasive  spindle cell metaplastic carcinoma breast cancer
T15	PROBLEM 333 359	a mass in her right breast
T16	PROBLEM 433 443	a 3cm mass
T17	TEST 477 482	an US
T18	PROBLEM 490 511	a complex cystic mass
T19	TEST 560 573	US guided CNB
T20	PROBLEM 585 631	malignant spindle cell carcinoma of the breast
T21	TEST 633 635	ER
T22	TEST 644 646	PR
T23	TEST 655 664	Her2 FISH
T24	TEST 670 675	ratio
T25	PROBLEM 734 770	2.7 cm focal rounded nodular density
T26	PROBLEM 847 898	rounded 2.8 x 1.9 cm area of decreased echogenicity
T27	PROBLEM 904 944	somewhat variegated internal echotexture
T28	PROBLEM 999 1018	postbiopsy hematoma
T29	TEST 1030 1033	CXR
T30	PROBLEM 1082 1096	irregular mass
T31	PROBLEM 1102 1126	heterogenous enhancement
T32	PROBLEM 1131 1147	central necrosis
T33	PROBLEM 1196 1248	Prominent nodes in Right axillary tail   Left breast
T34	PROBLEM 1254 1292	lobulated mass in upper outer quadrant
T35	TEST 1335 1348	InVitae panel
T36	TEST 1396 1399	MRI
T37	PROBLEM 1410 1439	3.5 x 3.2 x 2.6 cm round mass
T38	PROBLEM 1445 1483	irregular, slightly spiculated margins
T39	PROBLEM 1488 1537	rim enhancement in the outer central right breast
T40	PROBLEM 1609 1646	a 12 mm irregular mass enhancing mass
T41	PROBLEM 1669 1704	another similar 8 mm enhancing mass
T42	PROBLEM 1737 1753	the index lesion
T43	PROBLEM 1798 1825	the index right breast mass
T44	PROBLEM 1830 1857	associated satellite masses
T45	PROBLEM 1929 1961	Known biopsy proven 
 malignancy
T46	TEST 1963 1970	BI-RADS
T47	TEST 1999 2006	BI-RADS
T48	PROBLEM 2031 2074	Right outer central breast index malignancy
T49	PROBLEM 2092 2118	Two small satellite masses
T50	PROBLEM 2181 2224	Mildly prominent right axillary lymph nodes
T51	TEST 2236 2254	further evaluation
T52	TEST 2260 2270	ultrasound
T53	PROBLEM 2294 2339	Heterogenous hypermetabolic right breast mass
T54	PROBLEM 2356 2388	patient's known breast carcinoma
T55	PROBLEM 2390 2469	Associated minimally hypermetabolic non-enlarged bilateral axillary lymph nodes
T56	TEST 2507 2526	same day breast MRI
T57	PROBLEM 2531 2565	Indeterminate right adrenal nodule
T58	TEST 2590 2608	Further evaluation
T59	TEST 2630 2653	adrenal protocol CT/MRI
T60	PROBLEM 2704 2738	spindle cell metaplastic carcinoma
T61	TEST 2748 2762	repeat markers
T62	TEST 2786 2790	R US
T63	TREATMENT 2796 2810	research cores
T64	TREATMENT 2815 2832	placement of clip
T65	TEST 2875 2878	FNA
T66	TEST 2900 2903	MRI
T67	TEST 2911 2914	CNB
T68	TEST 2942 2944	Cr
T69	TREATMENT 3003 3024	neoadjuvant treatment
T70	PROBLEM 3078 3100	Abnormal liver enzymes
T71	PROBLEM 3109 3127	Hyperbilirubinemia
T72	PROBLEM 3132 3164	Common bile duct (CBD) stricture
T73	PROBLEM 3184 3197	CBD stricture
T74	PROBLEM 3214 3227	acholic stool
T75	PROBLEM 3232 3242	dark urine
T76	PROBLEM 3247 3285	GERD (gastroesophageal reflux disease)
T77	PROBLEM 3290 3300	mild, tums
T78	PROBLEM 3318 3336	HTN (hypertension)
T79	PROBLEM 3342 3359	Plantar fasciitis
T80	TREATMENT 3457 3476	oral contraceptives
T81	PROBLEM 3490 3499	Menopause
T82	PROBLEM 3526 3537	hot flashes
T83	TREATMENT 3551 3578	hormone replacement therapy
T84	TREATMENT 3644 3659	CHOLECYSTECTOMY
T85	TREATMENT 3661 3673	LAPAROSCOPIC
T86	TREATMENT 3684 3709	Common bile duct stenting
T87	TREATMENT 3723 3734	- Lap chole
T88	TREATMENT 3773 3785	HYSTERECTOMY
T89	PROBLEM 3799 3814	a large fibroid
T90	TREATMENT 3831 3887	Medications           Current Outpatient 
 Prescriptions
T91	TREATMENT 3890 3920	Medication Sig Dispense Refill
T92	TREATMENT 3925 3963	clotrimazole-betamethasone (LOTRISONE)
T93	TREATMENT 4006 4030	ibuprofen (ADVIL,MOTRIN)
T94	PROBLEM 4085 4089	Pain
T95	TREATMENT 4097 4118	omeprazole (PRILOSEC)
T96	TREATMENT 4182 4223	triamterene-hydrochlorothiazide (DYAZIDE)
T97	TREATMENT 4280 4302	predniSONE (DELTASONE)
T98	TREATMENT 4355 4366	medications
T99	PROBLEM 4937 4950	Breast cancer
T100	PROBLEM 4966 4972	Cancer
T101	PROBLEM 5007 5018	Lung cancer
T102	PROBLEM 5048 5062	Stomach cancer
T103	PROBLEM 5215 5223	distress
T104	PROBLEM 5328 5350	significant adenopathy
T105	PROBLEM 5368 5392	palpable lymphadenopathy
T106	PROBLEM 5397 5415	hepatosplenomegaly
T107	TEST 5434 5446	auscultation
T108	PROBLEM 5451 5458	wheezes
T109	PROBLEM 5460 5465	rales
T110	PROBLEM 5469 5476	rhonchi
T111	PROBLEM 5554 5561	murmurs
T112	PROBLEM 5563 5567	rubs
T113	PROBLEM 5569 5575	clicks
T114	PROBLEM 5579 5586	gallops
T115	PROBLEM 5604 5613	nontender
T116	PROBLEM 5615 5627	nondistended
T117	PROBLEM 5632 5638	masses
T118	PROBLEM 5642 5654	organomegaly
T119	PROBLEM 5666 5671	scars
T120	PROBLEM 5710 5714	mass
T121	PROBLEM 5716 5738	skin or nipple changes
T122	PROBLEM 5742 5756	axillary nodes
T123	PROBLEM 5758 5771	abnormal mass
T124	PROBLEM 5889 5903	focal findings
T125	PROBLEM 5907 5924	movement disorder
T126	PROBLEM 5953 5969	joint tenderness
T127	PROBLEM 5971 5980	deformity
T128	PROBLEM 5984 5992	swelling
T129	TEST 6008 6025	peripheral pulses
T130	PROBLEM 6037 6048	pedal edema
T131	PROBLEM 6053 6061	clubbing
T132	PROBLEM 6065 6073	cyanosis
T133	PROBLEM 6115 6121	rashes
T134	PROBLEM 6126 6149	suspicious skin lesions
T135	PROBLEM 6244 6269	right sided breast cancer
T136	PROBLEM 6359 6366	disease
T137	PROBLEM 6378 6392	the tumor size
T138	TREATMENT 6452 6476	neoadjuvant chemotherapy
T139	PROBLEM 6526 6536	her cancer
T140	TREATMENT 6619 6638	neoadjuvant therapy
T141	TREATMENT 6710 6740	a promising experimental agent
T142	PROBLEM 6822 6868	locally advanced triple negative breast cancer
T143	PROBLEM 6933 6951	metastatic disease
T144	TREATMENT 6993 7008	curative intent
T145	TREATMENT 7058 7084	the multimodality approach
T146	TREATMENT 7088 7111	breast cancer treatment
T147	TREATMENT 7143 7152	treatment
T148	TREATMENT 7166 7178	chemotherapy
T149	TREATMENT 7180 7187	surgery
T150	TREATMENT 7189 7205	hormonal therapy
T151	TREATMENT 7223 7240	radiation therapy
T152	TREATMENT 7336 7348	chemotherapy
T153	TREATMENT 7352 7375	the neoadjuvant setting
T154	TREATMENT 7407 7416	treatment
T155	TREATMENT 7449 7474	breast conserving surgery
T156	TREATMENT 7493 7518	the chemotherapy regimens
T157	TREATMENT 7588 7602	these regimens
T158	PROBLEM 7704 7757	her higher risk triple 
 negative metaplastic disease
T159	TREATMENT 7824 7841	weekly paclitaxel
T160	TREATMENT 7866 7877	doxorubicin
T161	TREATMENT 7883 7904	cyclophosphamide (AC)
T162	TREATMENT 8016 8037	an experimental agent
T163	TREATMENT 8053 8063	paclitaxel
T164	TREATMENT 8091 8114	an experimental therapy
T165	TEST 8279 8286	the MRI
T166	TEST 8288 8303	research biopsy
T167	TEST 8309 8313	Echo
T168	TEST 8315 8325	mammaprint
T169	TEST 8341 8349	the echo
T170	TEST 8363 8371	Her labs
T171	PROBLEM 8381 8403	an elevated creatinine
T172	TEST 8408 8416	Alk phos
T173	PROBLEM 8440 8450	dehydrated
T174	PROBLEM 8503 8512	her tumor
T175	PROBLEM 8779 8804	metaplastic breast cancer
T176	PROBLEM 8959 8963	AC/T
T177	PROBLEM 8973 8980	fatigue
T178	PROBLEM 8982 8992	neuropathy
T179	PROBLEM 8994 9015	skin and nail changes
T180	PROBLEM 9017 9025	myalgias
T181	PROBLEM 9027 9035	alopecia
T182	PROBLEM 9037 9053	myelosuppression
T183	PROBLEM 9055 9061	nausea
T184	TREATMENT 9180 9202	chemo teaching session
T185	TREATMENT 9229 9236	therapy
T186	PROBLEM 9464 9475	this cancer
T187	TEST 9548 9562	the gene panel
T188	Age 7 9	60
T189	ClinicalCondition 60 73	breast cancer
T190	Stage 48 53	early
R1	TumorDesc TumorDetails:T189 Desc:T190	
T191	TreatmentType 102 109	therapy
A1	NegationModalityVal T191 hypothetical_in_future
A2	TreatmentTypeVal T191 neoadjuvant
T192	Age 159 161	60
T193	ClinicalCondition 257 270	breast cancer
A3	ContinuityVal T193 new
T194	Histology 212 256	invasive  spindle cell metaplastic carcinoma
A4	HistoryVal T194 new
A5	EpisodeDescription T194 FirstOccurrence
T195	Site 200 205	right
R2	SiteOf Arg1:T195 Arg2:T193	
R3	TumorDesc TumorDetails:T193 Desc:T194	
T196	Datetime 306 318	October 2016
T197	Symptom 335 339	mass
A6	IsPresentOnFirstCancerDiagnosis T197 yes
A7	IsCausedByDiagnosedCancer T197 yes
T198	Site 353 359	breast
T199	Laterality 347 352	right
R4	LateralityOfSite Arg1:T199 Arg2:T198	
R5	SiteOf Arg1:T198 Arg2:T197	
R6	HappensAtOnDuring Arg1:T197 Arg2:T196	
T200	Datetime 414 423	11/30/16,
T201	Radiology 480 482	US
A8	IntentVal T201 diagnosis
T203	RadPathResult 492 511	complex cystic mass
A10	RadPathResultVal T203 Others
R7	ResultOfTest Desc:T203 Test:T201	
R8	HappensAtOnDuring Arg1:T201 Arg2:T200	
T204	Datetime 550 558	11/30/16
T205	Pathology 560 573	US guided CNB
A11	IntentVal T205 diagnosis
R9	HappensAtOnDuring Arg1:T205 Arg2:T204	
T206	Histology 585 617	malignant spindle cell carcinoma
A12	HistoryVal T206 new
A13	EpisodeDescription T206 FirstOccurrence
T207	BiomarkerName 633 635	ER
A14	HistoryVal T207 new
A15	EpisodeDescription T207 FirstOccurrence
T208	BiomarkerName 644 646	PR
A16	HistoryVal T208 new
A17	EpisodeDescription T208 FirstOccurrence
T209	BiomarkerName 655 659	Her2
A18	HistoryVal T209 new
A19	EpisodeDescription T209 FirstOccurrence
T210	Pathology 660 664	FISH
T211	BiomarkerResult 636 642	neg 0%
A20	HistoryVal T211 new
A21	EpisodeDescription T211 FirstOccurrence
A22	BiomarkerResultVal T211 Negative
T212	BiomarkerResult 647 653	neg 0%
A23	HistoryVal T212 new
A24	EpisodeDescription T212 FirstOccurrence
A25	BiomarkerResultVal T212 Negative
T213	BiomarkerResult 665 668	neg
A26	HistoryVal T213 new
A27	EpisodeDescription T213 FirstOccurrence
A28	BiomarkerResultVal T213 Negative
T214	RadPathResult 676 679	1.2
R10	BiomarkerRel Arg1:T211 Arg2:T207	
R11	BiomarkerRel Arg1:T212 Arg2:T208	
R12	BiomarkerRel Arg1:T213 Arg2:T209	
R13	ResultOfTest Desc:T214 Test:T210	
R14	TestOrProcedureReveals Test:T205 Desc:T206	
R15	TestOrProcedureReveals Test:T205 Desc:T207	
R16	TestOrProcedureReveals Test:T205 Desc:T208	
R17	TestOrProcedureReveals Test:T205 Desc:T209	
T215	Datetime 682 690	12/17/16
T216	Radiology 712 717	mammo
A29	IntentVal T216 diagnosis
T217	Site 691 700	Bilateral
R18	SiteOf Arg1:T217 Arg2:T216	
R19	HappensAtOnDuring Arg1:T216 Arg2:T215	
T218	RadPathResult 734 770;814 822	2.7 cm focal rounded nodular density BIRADS 0
A30	RadPathResultVal T218 NoDisease
T219	Site 778 785;806 812	lateral breast
T220	Laterality 800 805	right
R20	LateralityOfSite Arg1:T220 Arg2:T219	
R21	SiteOf Arg1:T219 Arg2:T218	
R22	ResultOfTest Desc:T218 Test:T216	
T221	Datetime 824 832	12/17/16
T222	Radiology 834 836	US
A31	IntentVal T222 diagnosis
T223	Site 839 845	breast
T224	Laterality 837 838	R
R23	LateralityOfSite Arg1:T224 Arg2:T223	
R24	SiteOf Arg1:T223 Arg2:T222	
R25	HappensAtOnDuring Arg1:T222 Arg2:T221	
T225	RadPathResult 847 944	rounded 2.8 x 1.9 cm area of decreased echogenicity with somewhat variegated internal echotexture
A32	RadPathResultVal T225 Unclear
R26	SiteOf Arg1:T223 Arg2:T225	
R27	ResultOfTest Desc:T225 Test:T222	
T226	Datetime 1020 1028	12/17/16
T227	Radiology 1030 1033	CXR
T228	RadPathResult 1036 1039	nml
A33	RadPathResultVal T228 NoDisease
R28	ResultOfTest Desc:T228 Test:T227	
R29	HappensAtOnDuring Arg1:T227 Arg2:T226	
T229	Datetime 1041 1049	12/30/16
T230	Radiology 1050 1053	MRI
A34	IntentVal T230 diagnosis
T231	Site 1054 1061	breasts
R30	SiteOf Arg1:T231 Arg2:T230	
R31	HappensAtOnDuring Arg1:T230 Arg2:T229	
T232	RadPathResult 1082 1194;1196 1297	irregular mass with heterogenous enhancement and central necrosis (with clip) in 9:00 6cmFN measures 2.9x2.5x3.3 Prominent nodes in Right axillary tail   Left breast with lobulated mass in upper outer quadrant, 7mm
R32	ResultOfTest Desc:T232 Test:T230	
T233	Datetime 1301 1309	01/15/17
T235	Datetime 1355 1363	01/15/17
T234	GenomicTest 1335 1342	InVitae
A35	GenomicTestType T234 GeneExpression
R33	HappensAtOnDuring Arg1:T234 Arg2:T233	
T236	Datetime 1386 1394	01/18/17
T237	Pathology 1396 1399	MRI
A36	IntentVal T237 diagnosis
T239	RadPathResult 1951 1972	malignancy (BI-RADS 6
A38	RadPathResultVal T239 InitialCancerDiagnosis
T240	Site 1921 1927	breast
T241	Laterality 1915 1920	Right
R34	LateralityOfSite Arg1:T241 Arg2:T240	
R35	SiteOf Arg1:T240 Arg2:T239	
R36	ResultOfTest Desc:T239 Test:T237	
T242	RadPathResult 1989 2009	Negative (BI-RADS 1)
A39	RadPathResultVal T242 NoDisease
T243	Site 1981 1987	breast
T244	Laterality 1976 1980	Left
R37	LateralityOfSite Arg1:T244 Arg2:T243	
R38	SiteOf Arg1:T243 Arg2:T242	
R39	ResultOfTest Desc:T242 Test:T237	
T245	Datetime 2275 2283	02/02/17
T3	Radiology 2285 2290	PETCT
A40	IntentVal T3 staging
R40	HappensAtOnDuring Arg1:T3 Arg2:T245	
T247	Datetime 2659 2667	02/02/17
T248	Histology 2704 2738	spindle cell metaplastic carcinoma
A42	HistoryVal T248 new
A43	EpisodeDescription T248 FirstOccurrence
T249	Datetime 2776 2784	02/03/17
T250	Radiology 2788 2790	US
A44	IntentVal T250 diagnosis
T251	Site 2786 2787	R
R41	SiteOf Arg1:T251 Arg2:T250	
T252	Pathology 2834 2837	FNA
A45	IntentVal T252 staging
T253	Site 2838 2851	axillary node
R42	SiteOf Arg1:T253 Arg2:T252	
T254	Datetime 2865 2873	02/03/17
R43	HappensAtOnDuring Arg1:T250 Arg2:T249	
R44	HappensAtOnDuring Arg1:T252 Arg2:T254	
T255	RadPathResult 2879 2887	negative
R45	ResultOfTest Desc:T255 Test:T252	
T256	Datetime 2891 2899	02/11/17
T257	Pathology 2900 2914	MRI guided CNB
A46	IntentVal T257 diagnosis
R46	HappensAtOnDuring Arg1:T257 Arg2:T256	
T258	TreatmentType 3015 3024	treatment
A47	TreatmentTypeVal T258 neoadjuvant
T259	ClinicalCondition 3078 3100	Abnormal liver enzymes
T260	Datetime 3101 3105	2012
R47	HappensAtOnDuring Arg1:T259 Arg2:T260	
T261	ClinicalCondition 3109 3127	Hyperbilirubinemia
T262	ClinicalCondition 3132 3164	Common bile duct (CBD) stricture
T263	Datetime 3165 3169	2012
R48	HappensAtOnDuring Arg1:T262 Arg2:T263	
T264	ClinicalCondition 3173 3197	post-chole CBD stricture
T265	Symptom 3214 3227	acholic stool
T266	Symptom 3232 3242	dark urine
T267	ClinicalCondition 3247 3251	GERD
T268	MedicationName 3296 3300	tums
R49	TreatmentAdministeredForProblem Treatment:T268 Prob:T267	
T269	ClinicalCondition 3318 3321	HTN
A48	ChronicVal T269 chronic
A49	ChronicVal T267 chronic
T270	Frequency 3301 3313	occasionally
R50	Temporal Arg1:T268 Arg2:T270	
T271	ClinicalCondition 3342 3359	Plantar fasciitis
T272	PatientCharacteristics 3391 3399	Menarche
T273	Age 3411 3413	12
R51	BeginsOnOrAt Arg1:T272 Arg2:T273	
T274	PatientCharacteristics 3426 3442	gravida 0 para 0
T275	MedicationName 3457 3476	oral contraceptives
A50	NegationModalityVal T275 negated
T276	ClinicalCondition 3490 3499	Menopause
T277	Age 3511 3513	57
R52	BeginsOnOrAt Arg1:T276 Arg2:T277	
T278	Symptom 3526 3537	hot flashes
T279	Duration 3515 3522	3 years
R53	HappensAtOnDuring Arg1:T278 Arg2:T279	
T280	TreatmentType 3551 3578	hormone replacement therapy
A51	NegationModalityVal T280 negated
T281	ProcedureName 3644 3659;3661 3673	CHOLECYSTECTOMY LAPAROSCOPIC
T10	Datetime 3675 3679	2007
R54	HappensAtOnDuring Arg1:T281 Arg2:T10	
T282	ProcedureName 3684 3709	Common bile duct stenting
T283	Datetime 3711 3715	2012
R55	HappensAtOnDuring Arg1:T282 Arg2:T283	
T284	ProcedureName 3719 3734	post- Lap chole
T285	Datetime 3743 3754	August 2011
R56	BeginsOnOrAt Arg1:T284 Arg2:T285	
T286	Datetime 3764 3768	2012
R57	EndsOnOrAt Arg1:T284 Arg2:T286	
T287	ProcedureName 3773 3785	HYSTERECTOMY
T288	Datetime 3787 3791	1987
R58	HappensAtOnDuring Arg1:T287 Arg2:T288	
T289	ClinicalCondition 3807 3814	fibroid
R59	TestOrProcedureConductedForProblem Test:T287 Prob:T289	
T290	SectionSkip 3823 3871;3874 4381	Current Medications           Current Outpatient Prescriptions   Medication Sig Dispense Refill    clotrimazole-betamethasone (LOTRISONE) 1-0.05 % cream 2 (two) times a day.      ibuprofen (ADVIL,MOTRIN) 800 mg tablet Take 800 mg by mouth once as needed for Pain.      omeprazole (PRILOSEC) 20 mg capsule Take 20 mg by mouth As needed after meals.      triamterene-hydrochlorothiazide (DYAZIDE) 37.5-25 mg capsule Take 1 capsule by mouth Daily.      predniSONE (DELTASONE) 5 mg tablet        No current facility-administered medications for this visit
A52	SectionSkipType T290 medications
T291	MaritalStatus 4471 4478	Married
A53	IsStoppedOrContinuing T291 stopped
T292	Employment 4591 4624	***** ***** ***** *****     *****
T293	Tobacco 4680 4685	Never
T294	Tobacco 4716 4720	None
T295	Alcohol 4737 4739	No
T296	Drugs 4754 4756	No
T297	MaritalStatus 4865 4873	divorced
T298	SDoH 4877 4903	Raised step son from age 3
T299	ClinicalCondition 4937 4950	Breast cancer
A54	ExperiencerVal T299 family
T300	ClinicalCondition 4966 4972	Cancer
A55	ExperiencerVal T300 family
T301	Age 4988 4990	40
R60	HappensAtOnDuring Arg1:T300 Arg2:T301	
T302	ClinicalCondition 5007 5018	Lung cancer
A56	ExperiencerVal T302 family
T303	ClinicalCondition 5048 5062	Stomach cancer
A57	ExperiencerVal T303 family
T304	SectionSkip 5137 5783;5786 6155	Physical Examination:   General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - sclera anicteric  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy, no hepatosplenomegaly  Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate, regular rhythm, normal S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  lap chole scars  Breasts - left breast normal without mass, skin or nipple changes or axillary nodes, abnormal mass palpable in the right breast at 9:00 6cm FN that measures 4x4cm  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
A58	SectionSkipType T304 physical_exam
T305	Age 6180 6182	60
T306	BiomarkerName 6204 6206	ER
A59	HistoryVal T306 new
A60	EpisodeDescription T306 FirstOccurrence
T307	BiomarkerName 6217 6219	PR
A61	HistoryVal T307 new
A62	EpisodeDescription T307 FirstOccurrence
T308	BiomarkerName 6230 6234	HER2
A63	HistoryVal T308 new
A64	EpisodeDescription T308 FirstOccurrence
T309	BiomarkerResult 6207 6215	Negative
A65	HistoryVal T309 new
A66	EpisodeDescription T309 FirstOccurrence
A67	BiomarkerResultVal T309 Negative
T310	BiomarkerResult 6220 6228	Negative
A68	HistoryVal T310 history
A69	EpisodeDescription T310 FirstOccurrence
A70	BiomarkerResultVal T310 Negative
T311	BiomarkerResult 6235 6243	Negative
A71	HistoryVal T311 new
A72	EpisodeDescription T311 FirstOccurrence
T312	ClinicalCondition 6256 6269	breast cancer
A73	ContinuityVal T312 new
T313	Site 6244 6249	right
R61	SiteOf Arg1:T313 Arg2:T312	
R62	BiomarkerRel Arg1:T306 Arg2:T309	
R63	BiomarkerRel Arg1:T307 Arg2:T310	
R64	BiomarkerRel Arg1:T308 Arg2:T311	
R65	TumorDesc TumorDetails:T312 Desc:T306	
R66	TumorDesc TumorDetails:T312 Desc:T307	
R67	TumorDesc TumorDetails:T312 Desc:T308	
T314	TreatmentType 6464 6476	chemotherapy
A74	NegationModalityVal T314 hypothetical_in_future
A75	TreatmentTypeVal T314 neoadjuvant
T315	TreatmentType 6631 6638	therapy
A76	TreatmentTypeVal T315 neoadjuvant
T316	ClinicalCondition 6855 6868	breast cancer
A77	ContinuityVal T316 new
T317	TumorCharacteristics 6296 6306	multifocal
A78	HistoryVal T317 new
A79	EpisodeDescription T317 FirstOccurrence
R68	TumorDesc TumorDetails:T312 Desc:T317	
T318	BiomarkerName 6839 6845	triple
A80	HistoryVal T318 new
A81	EpisodeDescription T318 FirstOccurrence
T319	BiomarkerResult 6846 6854	negative
A82	HistoryVal T319 new
A83	EpisodeDescription T319 FirstOccurrence
T320	LocalInvasion 6822 6838	locally advanced
A84	HistoryVal T320 new
A85	EpisodeDescription T320 FirstOccurrence
R69	BiomarkerRel Arg1:T319 Arg2:T318	
R70	TumorDesc TumorDetails:T316 Desc:T320	
R71	TumorDesc TumorDetails:T316 Desc:T318	
T321	Metastasis 6933 6943	metastatic
A86	NegationModalityVal T321 negated
A87	HistoryVal T321 new
A88	EpisodeDescription T321 FirstOccurrence
A89	TreatmentIntentVal T315 curative
A90	TreatmentIntentVal T314 curative
T322	TreatmentType 7166 7178	chemotherapy
A91	TreatmentIntentVal T322 curative
T323	TreatmentType 7180 7187	surgery
A92	TreatmentIntentVal T323 curative
T324	TreatmentType 7189 7205	hormonal therapy
A93	TreatmentIntentVal T324 curative
T325	TreatmentType 7223 7232	radiation
A94	TreatmentIntentVal T325 curative
A95	NegationModalityVal T322 hypothetical_in_future
A96	NegationModalityVal T323 hypothetical_in_future
A97	NegationModalityVal T324 hypothetical_in_future
A98	NegationModalityVal T325 hypothetical_in_future
T326	TreatmentType 7336 7348	chemotherapy
A99	NegationModalityVal T326 hypothetical_in_future
A100	TreatmentTypeVal T326 neoadjuvant
A101	TreatmentIntentVal T326 curative
T327	ProcedureName 7449 7474	breast conserving surgery
A102	NegationModalityVal T327 hypothetical_in_future
A103	IntentVal T327 treatment-curative
A104	TreatmentTypeVal T327 local
T328	ClinicalTrial 7644 7650	I-SPY2
T329	Cycles 7811 7813	12
T330	Frequency 7824 7830	weekly
T331	MedicationName 7831 7841	paclitaxel
A105	NegationModalityVal T331 hypothetical_in_future
A106	TreatmentTypeVal T331 neoadjuvant
A107	TreatmentIntentVal T331 curative
A108	TreatmentCategory T331 AntiNeoPlastics
T332	Cycles 7854 7855	4
T333	MedicationName 7866 7877	doxorubicin
A109	NegationModalityVal T333 hypothetical_in_future
A110	TreatmentTypeVal T333 neoadjuvant
A111	TreatmentIntentVal T333 curative
A112	TreatmentCategory T333 AntiNeoPlastics
T334	MedicationName 7883 7899	cyclophosphamide
A113	NegationModalityVal T334 hypothetical_in_future
A114	TreatmentTypeVal T334 neoadjuvant
A115	TreatmentIntentVal T334 curative
A116	TreatmentCategory T334 AntiNeoPlastics
R72	Temporal Arg1:T331 Arg2:T330	
R73	TreatmentDesc Therapy:T331 Desc:T329	
R74	TreatmentDesc Therapy:T333 Desc:T332	
R75	TreatmentDesc Therapy:T334 Desc:T332	
T335	Frequency 7905 7918	every 2 weeks
R76	Temporal Arg1:T333 Arg2:T335	
R77	Temporal Arg1:T334 Arg2:T335	
T336	ClinicalTrial 7957 7963	I-SPY2
T337	MedicationName 8053 8063	paclitaxel
A117	NegationModalityVal T337 hypothetical_in_future
A118	TreatmentTypeVal T337 neoadjuvant
A119	TreatmentIntentVal T337 curative
A120	TreatmentCategory T337 AntiNeoPlastics
T338	ClinicalTrial 8217 8223	I-SPY2
T339	Radiology 8283 8286	MRI
T340	Pathology 8297 8303	biopsy
T341	Radiology 8309 8313	Echo
T342	GenomicTest 8315 8325	mammaprint
A121	GenomicTestType T342 GeneExpression
T343	DiagnosticLabTest 8367 8371	labs
T344	LabTestResult 8384 8416	elevated creatinine and Alk phos
A122	LabTestResultVal T344 abnormal
R78	ResultOfTest Desc:T344 Test:T343	
T345	RadPathResult 8519 8538	Mammaprint low risk
R79	ExclusionCriteriaFor Arg1:T345 Arg2:T338	
T346	ClinicalCondition 8791 8804	breast cancer
A123	ContinuityVal T346 new
T347	Histology 8779 8790	metaplastic
A124	HistoryVal T347 new
A125	EpisodeDescription T347 FirstOccurrence
R80	TumorDesc TumorDetails:T346 Desc:T347	
T348	MedicationRegimen 8959 8964	AC/T,
A126	NegationModalityVal T348 hypothetical_in_future
A127	TreatmentTypeVal T348 neoadjuvant
A128	TreatmentIntentVal T348 curative
T349	Symptom 8973 8980	fatigue
A129	NegationModalityVal T349 hypothetical_in_future
T350	ClinicalCondition 8982 8992	neuropathy
A130	NegationModalityVal T350 hypothetical_in_future
T351	Symptom 8994 9015	skin and nail changes
A131	NegationModalityVal T351 hypothetical_in_future
T352	Symptom 9017 9025	myalgias
A132	NegationModalityVal T352 hypothetical_in_future
T353	Symptom 9027 9035	alopecia
A133	NegationModalityVal T353 hypothetical_in_future
T354	ClinicalCondition 9037 9053	myelosuppression
A134	NegationModalityVal T354 hypothetical_in_future
T355	Symptom 9055 9061	nausea
R81	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T349	
R82	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T350	
R83	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T351	
R84	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T352	
R85	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T353	
R86	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T354	
R87	ConditionOrTreatmentCausesProblem Treatment:T348 Prob:T355	
T356	ProcedureName 9092 9101	Medi-port
A135	NegationModalityVal T356 hypothetical_in_future
R88	HappensAtOnDuring Arg1:T235 Arg2:T234	
R89	HappensAtOnDuring Arg1:T236 Arg2:T237	
T202	SectionSkip 1410 1897	3.5 x 3.2 x 2.6 cm round mass with irregular, slightly spiculated margins and rim enhancement in the outer central right breast, middle depth. Approximately 15 mm anterior to the index mass there is a 12 mm irregular mass enhancing mass. In addition there is another similar 8 mm enhancing mass located 18 mm anterosuperior to the index lesion at the 10 o'clock position.  Taken together the index right breast mass and associated satellite masses span approximately 5.5 cm in AP extent.
A9	SectionSkipType T202 radiology_report
R90	HappensAtOnDuring Arg1:T247 Arg2:T248	
R91	HappensAtOnDuring Arg1:T249 Arg2:T252	
T238	LocalInvasion 6278 6294	locally advanced
R92	TumorDesc TumorDetails:T312 Desc:T238	
A37	NegationModalityVal T355 hypothetical_in_future
T246	Datetime 9359 9381	first week in February
T357	TreatmentType 9229 9236	therapy
A41	NegationModalityVal T357 planned_in_future
A136	TreatmentContinuityVal T357 planned
R93	HappensAfter Arg1:T357 Arg2:T246	
T358	Size 435 438	3cm
A137	HistoryVal T358 new
A138	EpisodeDescription T358 FirstOccurrence
T359	Symptom 439 443	mass
A139	IsPresentOnFirstCancerDiagnosis T359 yes
A140	IsCausedByDiagnosedCancer T359 yes
R94	SizeOf Arg1:T358 Arg2:T359	
R95	HappensAtOnDuring Arg1:T359 Arg2:T200	
T360	Site 447 458	9:00 6cm FN
R96	SiteOf Arg1:T360 Arg2:T359	
T361	Site 2037 2057	outer central breast
T362	Laterality 2031 2036	Right
R97	LateralityOfSite Arg1:T362 Arg2:T361	
T363	RadPathResult 2064 2074	malignancy
A141	RadPathResultVal T363 InitialCancerDiagnosis
T364	Size 2084 2090	3.5 cm
A142	HistoryVal T364 new
A143	EpisodeDescription T364 FirstOccurrence
R98	SizeOf Arg1:T364 Arg2:T363	
R99	SiteOf Arg1:T361 Arg2:T363	
R100	ResultOfTest Desc:T363 Test:T237	
T365	RadPathResult 2092 2118	Two small satellite masses
A144	RadPathResultVal T365 InitialCancerDiagnosis
T366	Site 2131 2175	12-15 mm anterior/superior to the index mass
R101	SiteOf Arg1:T366 Arg2:T365	
R102	ResultOfTest Desc:T365 Test:T237	
T367	LymphNodeInvolvement 2213 2224	lymph nodes
A145	HistoryVal T367 new
A146	EpisodeDescription T367 FirstOccurrence
T368	Site 2204 2212	axillary
T369	Laterality 2198 2203	right
R103	LateralityOfSite Arg1:T369 Arg2:T368	
R104	SiteOf Arg1:T368 Arg2:T367	
R105	TestOrProcedureReveals Test:T237 Desc:T367	
T370	Radiology 2260 2270	ultrasound
A147	NegationModalityVal T370 hypothetical_in_future
A148	IntentVal T370 diagnosis
T371	RadPathResult 2294 2321;2335 2339	Heterogenous hypermetabolic mass
A149	RadPathResultVal T371 InitialCancerDiagnosis
T372	Laterality 2322 2327	right
T373	Site 2328 2334	breast
R106	LateralityOfSite Arg1:T372 Arg2:T373	
R107	SiteOf Arg1:T373 Arg2:T371	
R108	ResultOfTest Desc:T371 Test:T3	
T374	LymphNodeInvolvement 2411 2438;2458 2470	hypermetabolic non-enlarged lymph nodes,
A150	HistoryVal T374 new
A151	EpisodeDescription T374 FirstOccurrence
T375	Site 2449 2457	axillary
T376	Laterality 2439 2448	bilateral
R109	LateralityOfSite Arg1:T376 Arg2:T375	
R110	SiteOf Arg1:T375 Arg2:T374	
R111	TestOrProcedureReveals Test:T3 Desc:T374	
T377	Metastasis 2559 2565	nodule
A152	HistoryVal T377 new
A153	EpisodeDescription T377 FirstOccurrence
T378	Site 2551 2558	adrenal
T379	Laterality 2545 2550	right
R112	LateralityOfSite Arg1:T379 Arg2:T378	
R113	SiteOf Arg1:T378 Arg2:T377	
T380	Size 2582 2588	2.3 cm
A154	HistoryVal T380 new
A155	EpisodeDescription T380 FirstOccurrence
R114	SizeOf Arg1:T380 Arg2:T377	
T381	Radiology 2647 2653	CT/MRI
A156	IntentVal T381 staging
T382	Site 2630 2637	adrenal
R115	SiteOf Arg1:T382 Arg2:T381	
R116	TestOrProcedureConductedForProblem Test:T381 Prob:T377	
R117	TestOrProcedureReveals Test:T3 Desc:T377	
A157	NegationModalityVal T258 hypothetical_in_future
T383	Histology 6504 6515	metaplastic
A158	HistoryVal T383 new
A159	EpisodeDescription T383 FirstOccurrence
R118	InclusionCriteriaFor Arg1:T383 Arg2:T315	
A160	NegationModalityVal T315 hypothetical_in_future
A161	NegationModalityVal T328 hypothetical_in_future
A162	NegationModalityVal T336 hypothetical_in_future
A163	NegationModalityVal T338 hypothetical_in_future
T384	Histology 7738 7749	metaplastic
A164	HistoryVal T384 new
A165	EpisodeDescription T384 FirstOccurrence
T385	BiomarkerName 7720 7726	triple
A166	HistoryVal T385 new
A167	EpisodeDescription T385 FirstOccurrence
T386	BiomarkerResult 7729 7737	negative
A168	HistoryVal T386 new
A169	EpisodeDescription T386 FirstOccurrence
A170	BiomarkerResultVal T386 Negative
R119	BiomarkerRel Arg1:T385 Arg2:T386	
T387	TumorCharacteristics 7708 7719	higher risk
A171	HistoryVal T387 new
A172	EpisodeDescription T387 FirstOccurrence
R120	InclusionCriteriaFor Arg1:T384 Arg2:T331	
R121	InclusionCriteriaFor Arg1:T385 Arg2:T331	
R122	InclusionCriteriaFor Arg1:T387 Arg2:T331	
R123	InclusionCriteriaFor Arg1:T387 Arg2:T333	
R124	InclusionCriteriaFor Arg1:T385 Arg2:T333	
R125	InclusionCriteriaFor Arg1:T384 Arg2:T333	
R126	InclusionCriteriaFor Arg1:T387 Arg2:T334	
R127	InclusionCriteriaFor Arg1:T385 Arg2:T334	
R128	InclusionCriteriaFor Arg1:T384 Arg2:T334	
A173	NegationModalityVal T345 hypothetical_in_future
T388	hpi_start 7 9	60
T389	hpi_start 1901 1911	IMPRESSION
T390	hpi_end 1403 1409	*****:
T391	hpi_end 3015 3025	treatment.
T392	ap_start 6159 6169	Assessment
T393	ap_end 9577 9582	sent.
